Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Sarcopenia 2Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Mucositis 1Metabolic Syndrome 1Lymphoma 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 7Folfox protocol 6pembrolizumab 5Drug Therapy 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4fludarabine 3XELOX 3Specimen Handling 3IFL protocol 3Cyclophosphamide 3Biopsy 3toripalimab 2tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × maltodextrin × Clear all
NCT06576986 2024-08-29

Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy

Federal University of Minas Gerais

Phase NA Recruiting
80 enrolled
GastrointestinalOther

Colonic Neoplasms, Diarrhea, Colorectal Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡